{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T21:14:30Z","timestamp":1761858870977,"version":"build-2065373602"},"reference-count":25,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004224","name":"Peter MacCallum Cancer Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004224","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","pathologyjournal.rcpa.edu.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.pathol.2021.07.006","type":"journal-article","created":{"date-parts":[[2021,10,8]],"date-time":"2021-10-08T17:09:52Z","timestamp":1633712992000},"page":"279-285","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["ROS1 rearrangements in non-small cell lung cancer: screening by immunohistochemistry using proportion of cells staining without intensity and excluding cases with MAPK pathway drivers improves test performance"],"prefix":"10.1016","volume":"54","author":[{"given":"Owen W.J.","family":"Prall","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judy","family":"Browning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Violeta","family":"Nastevski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shana","family":"Caporarello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bindi","family":"Bates","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chelsee A.","family":"Hewitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Arenas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gareth","family":"Lamb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerryn","family":"Howlett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rainier","family":"Arnolda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roshana","family":"Adeloju","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shani","family":"Stuart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiling","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Fellowes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen B.","family":"Fox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pathol.2021.07.006_bib1","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.2217\/fon-2016-0050","article-title":"ROS1 fusions in cancer: a review","volume":"12","author":"Uguen","year":"2016","journal-title":"Future Oncol"},{"key":"10.1016\/j.pathol.2021.07.006_bib2","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1158\/1078-0432.CCR-12-2851","article-title":"Molecular pathways: ROS1 fusion proteins in cancer","volume":"19","author":"Davies","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.pathol.2021.07.006_bib3","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41571-020-0408-9","article-title":"ROS1-dependent cancers - biology, diagnostics and therapeutics","volume":"18","author":"Drilon","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"year":"2016","series-title":"IASLC Atlas of ALK and ROS1 Testing in Lung Cancer","author":"Tsao","key":"10.1016\/j.pathol.2021.07.006_bib4"},{"author":"National Comprehensive Cancer Network","key":"10.1016\/j.pathol.2021.07.006_bib5"},{"author":"Australian Government Department of Health","key":"10.1016\/j.pathol.2021.07.006_bib6"},{"key":"10.1016\/j.pathol.2021.07.006_bib7","doi-asserted-by":"crossref","first-page":"922","DOI":"10.5858\/arpa.2017-0502-RA","article-title":"Biomarkers for ALK and ROS1 in lung cancer: immunohistochemistry and fluorescent in situ hybridization","volume":"142","author":"Luk","year":"2018","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.pathol.2021.07.006_bib8","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00428-016-2000-3","article-title":"Testing for ROS1 in non-small cell lung cancer: a review with recommendations","volume":"469","author":"Bubendorf","year":"2016","journal-title":"Virchows Arch"},{"key":"10.1016\/j.pathol.2021.07.006_bib9","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.jtho.2019.03.024","article-title":"Multicenter evaluation of a novel ROS1 immunohistochemistry assay (SP384) for detection of ROS1 rearrangements in a large cohort of lung adenocarcinoma patients","volume":"14","author":"Hofman","year":"2019","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.pathol.2021.07.006_bib10","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1016\/j.jtho.2019.07.005","article-title":"Assessment of a new ROS1 immunohistochemistry clone (SP384) for the identification of ROS1 rearrangements in patients with non-small cell lung carcinoma: the ROSING study","volume":"14","author":"Conde","year":"2019","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.pathol.2021.07.006_bib11","doi-asserted-by":"crossref","first-page":"735","DOI":"10.5858\/arpa.2019-0085-OA","article-title":"Correlation of ROS1 immunohistochemistry with ROS1 fusion status determined by fluorescence in situ hybridization","volume":"144","author":"Huang","year":"2020","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.pathol.2021.07.006_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0120422","article-title":"Detection of ROS1 gene rearrangement in lung adenocarcinoma: comparison of IHC, FISH and real-time RT-PCR","volume":"10","author":"Shan","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.pathol.2021.07.006_bib13","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/his.13076","article-title":"Screening for ROS1 gene rearrangements in non-small-cell lung cancers using immunohistochemistry with FISH confirmation is an effective method to identify this rare target","volume":"70","author":"Selinger","year":"2017","journal-title":"Histopathology"},{"key":"10.1016\/j.pathol.2021.07.006_bib14","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.lungcan.2013.11.019","article-title":"On the relevance of a testing algorithm for the detection of ROS1-rearranged lung adenocarcinomas","volume":"83","author":"Mescam-Mancini","year":"2014","journal-title":"Lung Cancer"},{"key":"10.1016\/j.pathol.2021.07.006_bib15","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1097\/PAS.0b013e3182960fa7","article-title":"ROS1 immunohistochemistry for detection of ROS1-rearranged lung adenocarcinomas","volume":"37","author":"Sholl","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2021.07.006_bib16","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/modpathol.2013.192","article-title":"Immunohistochemical detection of ROS1 is useful for identifying ROS1 rearrangements in lung cancers","volume":"27","author":"Yoshida","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2021.07.006_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0103333","article-title":"Screening of ROS1 rearrangements in lung adenocarcinoma by immunohistochemistry and comparison with ALK rearrangements","volume":"9","author":"Cha","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.pathol.2021.07.006_bib18","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.pathol.2019.08.006","article-title":"Australian consensus statement for best practice ROS1 testing in advanced non-small cell lung cancer","volume":"51","author":"Pavlakis","year":"2019","journal-title":"Pathology"},{"key":"10.1016\/j.pathol.2021.07.006_bib19","first-page":"2020","article-title":"Mutations in TP53 and other heterogeneous genes help to distinguish metastases from new primary malignancies","volume":"16","author":"Prall","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.pathol.2021.07.006_bib20","doi-asserted-by":"crossref","first-page":"48","DOI":"10.2144\/btn-2019-0059","article-title":"Improved next-generation sequencing pre-capture library yields and sequencing parameters using on-bead PCR","volume":"68","author":"McEvoy","year":"2020","journal-title":"Biotechniques"},{"key":"10.1016\/j.pathol.2021.07.006_bib21","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1038\/s41379-020-0545-9","article-title":"RAF1 rearrangements are common in pancreatic acinar cell carcinomas","volume":"33","author":"Prall","year":"2020","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2021.07.006_bib22","doi-asserted-by":"crossref","first-page":"e114","DOI":"10.1016\/j.jtho.2018.02.005","article-title":"GOPC-ROS1 rearrangement as an acquired resistance mechanism to osimertinib and responding to crizotinib combined treatments in lung adenocarcinoma","volume":"13","author":"Zeng","year":"2018","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.pathol.2021.07.006_bib23","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nature13385","article-title":"Comprehensive molecular profiling of lung adenocarcinoma","volume":"511","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.pathol.2021.07.006_bib24","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/modpathol.2011.198","article-title":"HER2 testing in gastric cancer: a practical approach","volume":"25","author":"Ruschoff","year":"2012","journal-title":"Mod Pathol"},{"year":"2019","series-title":"PD-L1 IHC 22C3 pharmDx Interpretation Manual \u2013 Head and Neck Squamous Cell Carcinoma (HNSCC)","author":"Agilent","key":"10.1016\/j.pathol.2021.07.006_bib25"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302521004670?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302521004670?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T16:28:50Z","timestamp":1758472130000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031302521004670"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S0031302521004670"],"URL":"https:\/\/doi.org\/10.1016\/j.pathol.2021.07.006","relation":{},"ISSN":["0031-3025"],"issn-type":[{"type":"print","value":"0031-3025"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ROS1 rearrangements in non-small cell lung cancer: screening by immunohistochemistry using proportion of cells staining without intensity and excluding cases with MAPK pathway drivers improves test performance","name":"articletitle","label":"Article Title"},{"value":"Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pathol.2021.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}